Influenza Vaccination for People with Chronic Diseases

Dear Colleagues,

The effect of influenza vaccination on decreasing the risk of influenza virus infection has been well reported before. Moreover, via the protection from the influenza vaccine, the risk of mortality and other complications of influenza virus infection could be significantly lowered. Therefore, it is highly recommended to receive the influenza vaccine annually, especially for high-risk populations such as patients with chronic diseases, the elderly, and healthcare providers. In addition to the protective effect from infection, the other potential benefits of influenza vaccination have also been demonstrated in previous research. However, detailed mechanism and clinical data on the additional effects of influenza vaccination among patients with chronic diseases are still lacking.

With a deeper understanding of the protective effect of the influenza vaccine on patients with chronic disease beyond infection protection, the long-term outcome of these patients could be further improved. Thus, we are pleased to invite you to submit research articles regarding the effectiveness and potential mechanism of the influenza vaccine among patients with chronic diseases. Clinical observational studies, randomized control trials, and basic molecular/animal investigation are all welcome for submission.

We look forward to receiving your contributions. 

Prof. Dr. Ju-Chi Liu
Dr. Wen-Rui Hao
Dr. Chun-Chao Chen
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.